VO
Vivo Opportunity Fund Holdings, L.P. disclosed a 10% stake in UNCY
Vivo Opportunity Fund Holdings, L.P. reported owning 10% of Unicycive Therapeutics, Inc. (UNCY) (3,911,375 shares) in a Schedule 13G filed Nov 16, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 16, 2026
- Source
- Schedule 13G